-
1 Comment
Paltac Corporation is currently in a long term downtrend where the price is trading 6.2% below its 200 day moving average.
From a valuation standpoint, the stock is 71.4% cheaper than other stocks from the Consumer Defensive sector with a price to sales ratio of 0.3.
Paltac Corporation's total revenue rose by 5.3% to $267B since the same quarter in the previous year.
Its net income has increased by 20.1% to $5B since the same quarter in the previous year.
Finally, its free cash flow fell by 143.3% to $-3B since the same quarter in the previous year.
Based on the above factors, Paltac Corporation gets an overall score of 3/5.
| Exchange | TSE |
|---|---|
| CurrencyCode | JPY |
| ISIN | JP3782200004 |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Dividend Yield | 3.1% |
|---|---|
| Target Price | 5157.5 |
| Beta | -0.13 |
| Market Cap | 251B |
| PE Ratio | 10.86 |
Paltac Corporation engages in the wholesale of cosmetics, daily necessities, and over-the-counter drugs in Japan. The company was founded in 1898 and is headquartered in Osaka, Japan. Paltac Corporation is a subsidiary of MediPal Holdings Corporation.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8283.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
